Bronchopulmonary dysplasia (BPD) is the most common adverse outcome in preterm neonates, and a high risk for early-onset emphysema and asthma. BPD is characterized by disrupted alveolar and microvascular development, due to a variety of pathogenic factors, such as hyperoxia, inflammation and dysbiosis. The resulting clinical manifestations are challenging and current treatment options are limited. To improve therapeutic options, it is imperative to understand underlying causes. Resident lung mesenchymal stromal cells (L-MSCs) are important for alveolar microvascularization, repair and regeneration. Here, we report the immediate effects of hyperoxia and antibiotics-induced reduced bacterial load on L-MSCs and alveolar development using the hyperoxia-induced BPD mouse model. Newborn mice were exposed to hyperoxia from postnatal day 4 (P4) to P14, with room air recovery from P14 to P21. Dams received antibiotics-supplemented water (ampicillin, gentamycin and vancomycin) from E15 to P21. Hyperoxia significantly impaired alveolar development between P14 and P21, whereas both hyperoxia and antibiotics exposure impaired lung microvascular development. Moreover, hyperoxia reduced the number of pericytes, proliferative mesenchymal progenitors, Col13a1POS matrix fibroblasts and P2RY14POS alveolar myofibroblasts. RNA-Seq of LY6A-sorted L-MSCs revealed differential expression of 103 genes in hyperoxia, 10 of which are related to mast cell biology. Antibiotics exposure also altered mesenchymal cell distribution, suggesting an additional impact on lung development. The transcriptomic landscape and distribution of important L-MSC subtypes, and microvascular development are affected by hyperoxia and antibiotics exposure in a BPD-mouse model. In conclusion, we show that hyperoxia and antibiotics-induced reduced bacterial loadaffect the mesenchymal cell population, which may contribute to the development of BPD.
Horik et al. (Mon,) studied this question.